Skip to main content
Premium Trial:

Request an Annual Quote

USC's Keck Med School Nets $24M Cancer -Omics Gift

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The University of Southern California’s Keck School of Medicine has landed a $24 million gift from media mogul Sumner Redstone to fund molecular research into prostate cancer, USC said this week.

The research will involve genomics and proteomics and will be led by David Agus, who is director of the USC Center for Applied Molecular Medicine and the USC Westside Prostate Cancer Center and a co-founder of Navigenics, the Keck School of Medicine said in a statement.

“We are working on new treatments for prostate cancer, and this tremendous philanthropic gift from Sumner allows our team to think outside of the box,” Argus said in a statement.

Argus said that the funding from Redstone “gives us free rein to think about the world in a different way, and he pushes us to be more entrepreneurial by focusing on incremental gains and taking risks in areas where there are more breakthrough opportunities.”

Agus’ research efforts focus on applying genomics and proteomics in cancer research aimed studying molecular switches involved in cancer progression and response to treatment.

“I was fortunate to meet Dr. Agus shortly after I was diagnosed with prostate cancer and since that time, I have benefitted from his expertise,” Redstone said.

“He quite literally saved my life, as he has done for many others,” he added.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.